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Supplementary Figures
. Preparation of polymer replica particles through mesoporous silica replication. 1 The same batch of mesoporous silica particle templates was used when preparing both PEG and PMA replica particles. Additional details are available in Fig. S2 and S3. S-3 
Supplementary Experimental Details
Preparation of PEG particles. MS particles (~500 nm) were synthesized based on a previously reported method 3 and PEG particles were prepared via a MS templating approach. 3, 2 Briefly, 6 mg of MS particles were washed with phosphate buffer (100 mM, pH 8) and incubated in 480 µL of 8-arm-PEG-NH 2 solution (5 mg mL -1 in phosphate buffer) with constant shaking for at least 8 h. Subsequently, the particles were washed three times with phosphate buffer. The pellet was dispersed in 400 µL of 8-arm-PEG-NHS solution (2 mg mL -1 in phosphate buffer) containing 10 µg of AF488-NHS (1 mg mL -1 in DMSO) and incubated for at least 2 h, where PEG was crosslinked and formed networks in the MS particles. After three washing cycles with water, MS templates were removed with a 2 M HF/8 M NH 4 F solution (pH ~5). Caution! HF is highly toxic. Extreme care should be taken when handling HF solution and only small quantities should be prepared. The resultant PEG particles were washed three times with water and resuspended in 500 µL of water.
Preparation of PMA particles. PMA PDA was synthesized via EDC-mediated amide bond formation between the carboxyl groups of PMA and the amine groups of PDA, based on a previously reported method. 4 A Malvern Zetasizer Nano ZS was used to obtain the zeta potential. Particle counting was performed on an Apogee Microflow cytometer. A Nikon A1R+ laser scanning confocal microscope was used for confocal microscopy. Additional characterization of this particle system (incl. super-resolution microscopy and atomic force microscopy) has been performed previously. 3 Hyaluronic acid (HA) cryogel fabrication. HA cryogels were prepared according to a previously published method. 7 Briefly, HA cryogels were prepared by EDC-mediated zerolength crosslinking of the HA polymer chains. 45 mg of HA were dissolved in water at 4 °C.
Stock solution of EDC (0.4 M) and NHS (0.5 M) were prepared in water and added in a 2:1 molar ratio to achieve a final HA concentration of 5 wt.% with crosslinking degree of 30% per disaccharide repeating unit. The precursor solution was vortexed for 20 s and cast into the chambers of a preassembled mould. The mould consisted of two microscope slides separated by a 1 mm thick acrylic polymer spacer. The filled mould was then placed in a circulating cooling bath at -12 °C for 72 h. Cryogels were thawed in water, removed from the glass mould, and stored at room temperature (21-23 °C) in water.
ECM gel and HA gel characterization. ECM gel was characterized based on a previously published method. 8 Briefly, ECM gels were thawed overnight at 4 °C and 6 µL of ECM gel were injected into chemotaxis 3D slides and incubated at 37 °C, 5% CO 2 for 30 min. Gels were fixed using 2.5% glutaraldehyde solution for 40 min at room temperature mixed in a 2:1 molar ratio in PBS. The gels were dehydrated using a lint-free tissue and rehydrated in ~50 µL of EDC/NHS solution. After 25 min incubation at room temperature (21-23 °C) the gels were washed in PBS, rehydrated in a Rhodamine B solution (~100 µg ml -1 ) and incubated overnight at 4 °C. Before imaging, the HA gels were washed at least three times with PBS to remove non-reacted dye. Images were taken on a Nikon confocal microscope using a 40× water immersion objective (1.15 NA) or a 60× oil immersion objective (1.4 NA).
Preparation of ECM/HA gel filled 3DKUBE chamber. Half-filled chamber:
For experiments with ECM gels, a stock of ECM gel was thawed overnight at 4 °C. The next day, a chilled (4 °C) pipette tip was used to pipette 60 µL of ECM gel into a chilled (4 °C) 3DKUBE chamber. After addition of the ECM gel, four 3D insert PS scaffolds were immersed in the liquid ECM gel to confer additional stability to the gel during flow experiments. Before immersion, the PS scaffolds were soaked in ethanol and washed three times in PBS to remove any air bubbles in the scaffold. The 3DKUBE chambers were then put in a humidified chamber and incubated at 37 °C for 1 h to allow for gelation. Fully filled chamber: For experiments with HA gels, HA cryogels were prepared as described above.
Four HA gel discs, cut using a biopsy punch (6 mm diameter), were placed on top of each other into the 3DKUBE chamber.
Flow setup. The flow setup consisted of a 1.7 mL microcentrifuge tube, a flow chamber (an assembled 3DKUBE), a peristaltic pump (Ismatec-Reglo Digital MS-CA4/12-100) and peristaltic pump tubing (PharMed, ID 0.76 mm). Before the experiment, the tubing was thoroughly rinsed for 20 min with water and PBS. The 3DKUBE chamber containing the ECM/HA gel was completely filled with PBS. The 3DKUBE experiments were run in "independent mode", meaning that a silicon gasket was used to separate the two chambers in a fully assembled 3DKUBE unit ( Figure S1 and S2). The unit was then connected to the tubing in a drop-to-drop fashion to avoid introduction of air bubbles. Before the experiment, the 3DKUBE was flushed with PBS for 15 min at a flow rate of 70 µL min -1 to ensure an even distribution of PBS. In the meantime, a tube containing 5 × 10 8 particles in 600 µL was prepared and samples were taken to determine the initial particle concentration, taking the dilution of the fluidic system into account. The total volume of the flow setup was 1.2 mL which corresponds to the blood volume of a mouse (20 g body weight). 9 Once the particlecontaining tube was in the flow path, the open-loop system was switched to the closed-loop configuration to allow for particle circulation. Samples were taken at designated time points
